SureTrader
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

Focalin sales are steady

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
fred198484 Member Profile
 
Followed By 2
Posts 428
Boards Moderated 0
Alias Born 07/13/16
160x600 placeholder
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/5/2017 8:05:20 AM
Intellipharmaceutics Announces Receipt of Nasdaq Notice "GlobeNewswire Inc." - 12/5/2017 8:00:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 12/4/2017 5:21:01 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/30/2017 10:51:14 AM
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical "GlobeNewswire Inc." - 11/30/2017 10:45:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 10/20/2017 5:20:34 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 10/18/2017 3:20:22 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/16/2017 6:03:43 AM
Intellipharmaceutics Announces Closing of US$4 Million Financing "GlobeNewswire Inc." - 10/13/2017 5:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/13/2017 6:04:15 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/12/2017 4:07:48 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/11/2017 8:07:45 AM
Intellipharmaceutics Announces US$4 Million Registered Direct Offering "GlobeNewswire Inc." - 10/11/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/10/2017 5:25:56 PM
Intellipharmaceutics Announces Third Quarter 2017 Results "GlobeNewswire Inc." - 10/10/2017 5:20:59 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/25/2017 7:12:00 AM
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA "GlobeNewswire Inc." - 9/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/20/2017 5:18:47 PM
Intellipharmaceutics Announces Receipt of Nasdaq Notice "GlobeNewswire Inc." - 9/20/2017 5:10:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/5/2017 2:43:50 PM
Intellipharmaceutics Provides Operational Update "GlobeNewswire Inc." - 9/5/2017 2:35:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/1/2017 8:10:22 AM
Intellipharmaceutics Appoints New Chief Financial Officer "GlobeNewswire Inc." - 9/1/2017 8:00:00 AM
Monteverde & Associates PC Invites IntelliPharmaCeutics International Inc. Shareholders with Losses in Excess of $1... "PR Newswire (US)" - 8/15/2017 4:52:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/8/2017 3:06:36 PM
fred198484   Friday, 11/10/17 11:52:02 AM
Re: None
Post # of 32277 
Focalin sales are steady


Bloomberg Intelligence: Molecule Detail
Molecule DEXMETHYLPHENIDATE HCL
View TRX Count By Payment Type By Week

PAR PHARMA

Payment Type 11/03/2017 10/27/2017 10/20/2017 10/13/2017 10/06/2017 09/29/201

Total 6.21k 6.28k 6.16k 6.10k 5.98k 6.20

Source: Symphony Health Solutions 



Bloomberg Intelligence: Molecule Detail
Molecule DEXMETHYLPHENIDATE HCL
View TRX Dollars By Payment Type By Week

PAR PHARMA

Payment Type 11/03/2017 10/27/2017 10/20/2017 10/13/2017 10/06/2017 09/29/201

Total 1.65M 1.68M 1.64M 1.62M 1.58M 1.63

Source: Symphony Health Solutions 


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist